Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
TOPICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2019/230750
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide an ointment preparation in which both separation over time and discoloration over time are suppressed. Both separation over time and discoloration over time are suppressed in: a topical composition containing (A) 30–60 weight% of zinc chloride, a specific (B) inorganic powder and a specific (C) additive, and (D) a solvent; and a topical composition containing (A) 30–60 weight% of zinc chloride, a specific (B) inorganic powder, and (D) a solvent.

Inventors:
SHIGEYAMA MASATO (JP)
NAGIRI TOSHIYA (JP)
TAKEUCHI YUKI (JP)
MIMA YU (JP)
SHIRAI KATSUNORI (JP)
TERAO TOSHIMITSU (JP)
Application Number:
PCT/JP2019/021182
Publication Date:
December 05, 2019
Filing Date:
May 29, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
JINNO INST (JP)
OTSUKA PHARMA FACTORY INC (JP)
International Classes:
A61K33/30; A61K9/06; A61K9/10; A61K47/02; A61K47/10; A61K47/32; A61K47/38; A61P17/00
Domestic Patent References:
WO2016199907A12016-12-15
WO2007148832A12007-12-27
WO2018105739A12018-06-14
Foreign References:
JP2011121932A2011-06-23
JPS52102417A1977-08-27
JP2007520551A2007-07-26
Other References:
MAHO TAGUCHI, MASATO SHIGEYAMA,NAHOMI ITO,NORIKO OGAWA,CHISATO TAKAHASHI,MIKIO MURATA,NOBUMITSU HANIOKA, HIROMITSU YAMAMOTO,HITOMI: "Preparation and Evaluation of Modified Mohs Paste without Starch", THE PHARMACEURICAL SOCIETY OF JAPAN , vol. 137, no. 4, 1 January 2017 (2017-01-01), pages 477 - 484, XP055662266, ISSN: 0031-6903, DOI: 10.1248/yakushi.16-00248
SUMIKO TAKATSUKA; HIROKI FUJIKAWA; TATSUYA TAKENOUCHI: "Minimally Invasive Treatment for Skin Cancer", JOURNAL OF NIIGATA CANCER CENTER HOSPITAL, vol. 53, no. 1, 28 February 2017 (2017-02-28), pages 6 - 10, XP009524878, ISSN: 0549-4788
MEDICAL JOURNAL, vol. 41, no. 9, 2005, pages 2289 - 2294
PHARMACEUTICS, vol. 75, no. 4, 2015, pages 264 - 270
THE PHARMACEUTICAL SOCIETY OF JAPAN, vol. 137, no. 4, 2017, pages 477 - 484
See also references of EP 3804734A4
Attorney, Agent or Firm:
TANAKA, Junya et al. (JP)
Download PDF: